✦ LIBER ✦

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS

✍ Scribed by Marcellin, P.; Cooper, C.; Balart, L.A.; Larrey, D.G.; Box, T.D.; Yoshida, E.; Lawitz, E.; Buggisch, P.; Ferenci, P.; Weltman, M.; Labriola-Tompkins, E.; Le Pogam, S.; Nájera, I.; Thomas, D.N.; Hooper, G.; Shulman, N.; Zhang, Y.; Navarro, M.T.; Lim, C.Y.; Brunda, M.; Yetzer, E.S.; Terrault, N.

Book ID: 123301539
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 65 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61204-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1123 RESPONSE-GUIDED THERAPY WITH BOCEP

P1123 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS INFECTED WITH HCV GENOTYPE 1: INTERIM RESULTS FROM THE TriCo STUDY

✍ Ferenci, P.; Flisiak, R.; Caruntu, F.A.; Lengyel, G.; Hohmann, M.; Bakalos, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

828 TREATMENT WITH PEGINTERFERON ALFA-2A

828 TREATMENT WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN OLDER HCV GENOTYPE 1 PATIENTS WITH POSITIVE PROGNOSTIC FACTORS LEADS TO HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE

✍ K.R. Reddy; D. Messinger; M. Popescu; S.J. Hadziyannis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

124 HIGH-DOSE PEGINTERFERON ALFA-2A (40K

124 HIGH-DOSE PEGINTERFERON ALFA-2A (40KD) INDUCTION THERAPY AND STANDARD RIBAVIRIN ENHANCES EARLY BUT NOT SUSTAINED VIROLOGICAL RESPONSES IN HCV GENOTYPE 1 PATIENTS: FINAL CHARIOT STUDY RESULTS

✍ S. Roberts; M. Weltman; D.H.G. Crawford; W.S.C. Cheng; W. Sievert; G. McCaughan; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

[613] VIROLOGICAL RESPONSE AT 4 AND 12 W

[613] VIROLOGICAL RESPONSE AT 4 AND 12 WEEKS PREDICT HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN GENOTYPE 1 PATIENTS TREATED WITH PEGINTERFERON a-2a (40 kD) PLUS RIBAVIRIN

✍ P. Marcellin; S.J. Hadziyannis; T. Berg; J.M. Sanchez-Tapias; J.-P. Bronowicki; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Response-Guided Therapy With Boceprevir

Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaïVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1

✍ Manns, Michael P. ;Poordad, Fred ;Bacon, Bruce R. ;Bruno, Savino ;Esteban, Rafae 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 258 KB

1218 HIGH SUSTAINED VIROLOGICAL RESPONSE

1218 HIGH SUSTAINED VIROLOGICAL RESPONSE (SVR) RATE AFTER DANOPREVIR FOR ONLY 14 DAYS ASSOCIATED WITH PEG-INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE CHRONIC HCV GENOTYPE 1 PATIENTS

✍ Larrey, P.; Carenco, C.; Guyader, D.; Boyer, N.; Benhamou, Y.; Daniélou, H.; Pag 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB